£81.81

It has never been this cheap. We have no record of a lower price.

£82 today · cheaper than every other day in the last 3 months

Springer Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 50 days · 50 data points (no recent data)

Historical
Generating forecast…
£86.38 £81.35 £82.45 £83.55 £84.64 £85.74 £86.84 25 July 2026 06 August 2026 18 August 2026 30 August 2026 12 September 2026
View at Amazon ↗

Price data last checked 41 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 50 days • 2 price levels

Days at Price
Current Price
5 days · current 45 days 0 11 23 34 45 £82 £86 Days at Price

Price Analysis

Most common price: £86 (45 days, 90.0%)

Price range: £82 - £86

Price levels: 2 different prices over 50 days

Description
The renewal of interest in excitatory amino acids in the 1980s has altered the direction of neurobiology. L-Glutamate, widely regarded as a general perpetu- ator of nonspecific excitation, has become generally regarded as a widely dis- tributed and important neurotransmitter in the CNS. In the past three decades evidence has accumulated that excitatory amino acids are involved in many neurological diseases and that pharmacological intervention may offer pros- pects of novel and more effective therapies. Numerous studies on experimen- tal animals demonstrate that excitatory amino acid antagonists have anxio- lytic, antiepileptic and muscle relaxant effects. Particular interest has developed in the possible neuroprotective efficacy of excitatory amino acid receptor antagonists in neurological diseases such as hypoxia/ischemia, hypo- glycemia, epilepsy, and chronic neurodegenerative disorders (Huntington's, Alzheimer's, and Parkinson's disease, amyotrophic lateral sclerosis, and AIDS). Thus, the drugs changing neurotransmission mediated by excitatory amino acids possess potential therapeutic value. This volume is part of the Schering Research Foundation Workshop Series. It is the goal of the Schering Research Foundation to promote the asso- ciation between industrial and basic research. The support and the organiza- tion of highly qualified symposia belong to the armamentarium by which this purpose is fulfilled, and we are convinced that the workshop "Excitatory Amino Acids and Second Messenger Systems" has contributed to this. Gunter Stock Ursula-F.

Product Specifications
Brand
Springer
Format
paperback
ASIN
3662226685
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain
Amazon UK
Release Date
23 August 2014
Listed Since
06 August 2014

Barcode

No barcode data available

Similar Products You Might Like

Nicotinic Acetycholine Receptors – From Molecular Biology to Cognition
96% match

Nicotinic Acetycholine Receptors – From Molecular Biology to Cognition

Odile Jacob

£66.00 04 Sep 2026
Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)
96% match

Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)

Springer

£82.93 24 Sep 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
96% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Elsevier

£105.39 12 Sep 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
96% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Elsevier

£104.49 01 Oct 2026
International Review of Neurobiology: Vol 54: Volume 54
96% match

International Review of Neurobiology: Vol 54: Volume 54

Elsevier

£45.81 08 Sep 2026
Ionotropic Glutamate Receptor Technologies: 106 (Neuromethods, 106)
95% match

Ionotropic Glutamate Receptor Technologies: 106 (Neuromethods, 106)

Humana

£76.93 19 Sep 2026
Ionotropic Glutamate Receptor Technologies: 106 (Neuromethods, 106)
95% match

Ionotropic Glutamate Receptor Technologies: 106 (Neuromethods, 106)

Humana

£51.93 11 Sep 2026
Receptor-Receptor Interactions in the Central Nervous System: 140 (Neuromethods, 140)
95% match

Receptor-Receptor Interactions in the Central Nervous System: 140 (Neuromethods, 140)

Humana

£80.65 11 Sep 2026
Advances in Neuropharmacology: Drugs and Therapeutics
95% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£77.00 26 Sep 2026
Chemical Biology of Neurodegeneration: Molecular Approach
95% match

Chemical Biology of Neurodegeneration: Molecular Approach

Wiley

£104.00 16 Sep 2026
Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)
95% match

Muscarinic Receptor: From Structure to Animal Models: 107 (Neuromethods, 107)

Humana

£84.46 24 Sep 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
95% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£104.34 17 Sep 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
95% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£79.26 11 Sep 2026
Neurochemistry: Molecular and Clinical Applications Book
95% match

Neurochemistry: Molecular and Clinical Applications Book

£129.14 01 Oct 2026
Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)
95% match

Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)

Springer

£43.23 23 Sep 2026
Amines and Their Metabolites: 2 (Neuromethods, 2)
95% match

Amines and Their Metabolites: 2 (Neuromethods, 2)

Humana

£87.00 11 Sep 2026
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
95% match

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Springer

£160.91 11 Sep 2026
Purinergic Signaling in Neuroinflammation
95% match

Purinergic Signaling in Neuroinflammation

£64.26 18 Sep 2026
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
95% match

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Springer

£148.21 11 Sep 2026
EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)
95% match

EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)

£58.38 18 Sep 2026